VICTORIA, June 12, 2017 /CNW/ - Emerald Health
Therapeutics Inc. (TSXV: EMH; OTCQX:TBQBF) ("Emerald" or the
"Company") is pleased to announce it has qualified for trading
on the OTCQX® Best Market, operated by OTC Markets Group. The
Company begins trading today on the OTCQX under the ticker symbol
"TBQBF".
"We look forward to being more visible and investable for U.S.
investors by trading on the OTCQX Market," said Avtar Dhillon, MD, Executive Chairman of Emerald
Health Therapeutics. "With the recent announcement of our
transformational joint venture with Village Farms International, a
leader in greenhouse growing, we view trading on the OTCQX Market
as the logical next step for building awareness, visibility, and
liquidity for the company and its shareholders."
"We welcome Emerald Health Therapeutics to our family of
established, investor-focused OTCQX companies," said Jason Paltrowitz, Executive Vice President of
Corporate Services at OTC Markets Group. "Trading on OTCQX will
enable Emerald Health to leverage its existing TSX Venture listing
and provide an efficient and transparent trading market for U.S.
investors. We look forward to supporting Emerald Health's continued
growth."
U.S. investors can find current financial disclosure and
Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Emerald Health Therapeutics was sponsored for OTCQX by McMillan
LLP, a qualified 3rd party firm responsible for providing guidance
on OTCQX requirements and recommending membership.
Join us on our journey of making lives better through
cannabis science.
Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. (TSXV: EMH;
OTCQX:TBQBF) operates primarily through Emerald Health
Botanicals Inc. ("Botanicals"), a wholly owned subsidiary of the
Company and a Licensed Producer under the Access to Cannabis for
Medical Purposes Regulations (the "ACMPR"). Botanicals is
authorized to cultivate and sell both dried medical cannabis
flowers and medical cannabis oils in Canada. Botanicals currently operates an
indoor cultivation facility in Victoria,
British Columbia, and plans to construct a much larger
purpose built hybrid greenhouse facility on 32 acres in metro
Vancouver. Botanicals prides
itself on being one of Canada's
most medically focused licensed producers and on having one of the
industry's most qualified management teams with respect to
pharmaceutical drug discovery, development and distribution.
Botanicals intends to capture unique niches in both the medical and
future adult use cannabis markets through its proprietary strains,
defensible intellectual property, and superb client experience.
Please visit
http://www.emeraldhealth.ca/ for more
information.
"Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release."
SOURCE Emerald Health Therapeutics, Inc.